10Jul
Antitrust Enforcers Unlikely to Lessen Scrutiny of Healthcare Mergers During Pandemic
COVID-19 has financially stressed the U.S. healthcare system in several ways. In many cities, hospitals have needed to add healthcare capacity (especially ICU beds) to serve rapidly increasing numbers of COVID-19 patients. At the same time, many states have mandated suspension of elective procedures, which typically generate most hospital revenue. Moreover, many non-COVID-19 patients are avoiding or delaying healthcare treatments, further depriving providers of income......
By:
Perkins Coie
Source Url: https://www.jdsupra.com/legalnews/antitrust-enforcers-unlikely-to-lessen-89614/
Related
Consonance Capital Partners (CCP) has announced it will sell Enclara Healthcare to Humana. Enclara,...
Read More >
We recently reported that on June 11, 2019, a three-judge panel of the U.S. Court of Appeals for the...
Read More >
The IRS has published Final Regulations finalizing its prior guidance that partners in a partnership...
Read More >
When there is a post-merger dispute between the representative of the selling stockholders and the b...
Read More >
Businesses in the construction industry face a range of labor and employment issues related to COVID...
Read More >
In today’s highly competitive healthcare environment, investors may find themselves in an auction p...
Read More >